The role of tau as a microtubule-associated protein in neurons is well established. They play major roles in preserving the stability of microtubules in axons and are widely distributed in central nervous system (CNS) neurons. However, in a variety of neurodegenerative disorders collectively known as tauopathies, aberrant assembly of tau into insoluble aggregates is accompanied by synaptic dysfunction and neural cell death.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V87846 | IONIS-MAPTRx sodium | IONIS-MAPTRx sodium is the first antisense oligonucleotide (ASO) that lowers Tau. | |
|
V70069 | JG-23 | 2640819-75-4 | JG-23 is a 4-chloromodified analog that promotes t-tau degradation. |
|
V138268 | JNJ-64326067 | 2173357-28-1 | JNJ-64326067 is an aggregated tau protein binder with blood-brain barrier permeability and a Ki value of 2.4 nM. |
|
V138924 | Lithium orotate | 5266-20-6 | Lithium orotate is an orally effective lithium supplement with low binding capacity that can bypass amyloid aggregation in mouse models of Alzheimer's disease (AD). |
|
V111116 | Lithium salicylate | 552-38-5 | Lithium salicylate (LiS) is an orally effective lithium salt. |
|
V87850 | MAO-B-IN-31 | MAO-B-IN-31 (Compound 30) is a potent and selective monoamine oxidase B inhibitor with IC50 of 41 nM. | |
|
V139428 | MAO-B-IN-45 | 3069915-36-9 | MAO-B-IN-45 is a dual inhibitor of ferroptosis and MAO-B. |
|
V70066 | MG-2119 | 1065500-40-4 | MG-2119 is a potent monomeric tau and α-syn aggregation inhibitor. |
|
V119648 | Moponetug | 3031519-40-8 | Moponetug is a humanized IgG1κ antibody that targets MAPT, with a corresponding isotype control being the human IgG1 kappa isotype control. |
|
V140407 | MRL828 | 3115333-82-6 | MRL828, based on ATTEC technology, combines a Tau pathotropic ligand with a modified guanine moiety to selectively target aggregated Tau protein and clear it via the ALP pathway. |
|
V141822 | O-GlcNAcase-IN-5 | 690215-80-6 | O-GlcNAcase-IN-5 is a selective O-GlcNAcase inhibitor. |
|
V141903 | ONC-841 | ONC-841 is a humanized monoclonal antibody that can cross the blood-brain barrier and targets SIGLEC10. | |
|
V142895 | PNT001 | PNT001 is a human IgG1 monoclonal antibody (mAb) that targets cis-phosphorylated Tau protein (cis-pT231 Tau). | |
|
V87848 | QC-01–175 | 2267290-96-8 | QC-01-175 is a heterobifunctional molecule that degrades abnormal tau. |
|
V143846 | RA-PR058 | RA-PR058 is an orally effective ramarin derivative with blood-brain barrier permeability, exhibiting multi-target regulatory effects and favorable pharmacokinetic properties. | |
|
V106305 | RI-AG03 | RI-AG03 is an orally active peptide Tau aggregation inhibitor that can penetrate the blood-brain barrier. | |
|
V117407 | RI-AG03 acetate | RI-AG03 acetate is the acetate form of RI-AG03. | |
|
V85832 | SB1617 | ||
|
V144827 | SGK1-IN-7 | 3109982-58-0 | SGK1-IN-7 is an SGK1 inhibitor that can cross the blood-brain barrier, with an IC50 value of 0.72 μM. |
|
V32942 | Flortaucipir (T-807; AV-1451) | 1415379-56-4 | T807 is a new tau positron emission tomography (PET) tracer. |